TRIPS transition period extensions for least-developed countries
The heavy disease burden on LDCs, including for HIV, Hepatitis C and TB, provides an urgent and compelling case for the international community to take all measures possible to protect and extend the health of the people living in these countries.
Related feature storiesSuccess with PrEP: next steps to support policy decisions in southern and eastern Africa
29 October 2014Ensuring access to generic antiretroviral medicines in low- and middle-income countries
29 October 2014Harnessing the power of technology for social transformation
27 October 2014